NCT00778115View on ClinicalTrials.gov

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Loperamide HCl 2 mg and simethicone 125 mg tablets

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778115 - Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions | Biotech Hunter | Biotech Hunter